Liu et al. in 1998 reported PSMA itself internalizes efficiently through clathrin-coated vesicles [36], and in metastatic prostate cancer cells, receptor expression is 100–1000 times higher than in normal prostate tissue [37]. This evidence concerns the gene FOLH1 and prostate carcinoma.